Zosano Pharma independent director resigns
Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share
Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet
Bruce Steel resigned as a class II independent director of Zosano Pharma Corp., effective Dec. 13.
Steel's resignation is not the result of any disagreement with the company on any matter relating to its operations, policies or practices.
Additionally, the board decided to reduce its size to five members, effective upon Steel's resignation.
